Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo.
Vectors based on lentiviruses such as human immunodeficiency virus (HIV) type-1 have many advantages for gene therapy, including the ability to infect non-dividing cells, long-term transgene expression and the absence of induction of an inflammatory/immune response. This study was initiated to determine whether lentiviruses would efficiently transfer genes to both neonatal and adult cardiac cells in culture and, by direct injection, to the heart in vivo. A three-plasmid expression system, including a packaging defective helper construct, a plasmid coding for a heterologous (VSV-G) envelope protein and a vector construct harboring reporter genes - E-GFP (enhanced green fluorescent protein) and puro (puromycin-resistance protein) was used to generate pseudotyped HIV-1 particles by transient transfection of human embryonic kidney 293T cells. We demonstrated efficient gene transfer into neonatal and adult cardiac myocytes in vitro and identified conditions in which virtually 100 % of cultured neonatal and 70 % of adult cardiac myocytes express the reporter gene. Transduction of adult cardiac myocytes with high titre lentiviral vectors did not affect the cell number, morphology or viability compared to untransduced cells. We delivered HIV-1-based vectors to the intact heart by direct injection. Hearts transduced with pseudotyped HIV-1 vectors showed levels of transgene expression comparable to that achieved by adenovirus vectors. This study demonstrates for the first time that lentivirus-based vectors can successfully transduce adult cardiomyocytes both in vitro and in vivo, and opens up the prospect of lentivirus-based vectors becoming an important gene delivery system in the cardiovascular field.
Zhao
Jing
J
Department of Medicine, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK.
Pettigrew
Gavin J
GJ
Thomas
Joan
J
Vandenberg
Jamie I
JI
Delriviere
Luc
L
Bolton
Eleanor M
EM
Carmichael
Andrew
A
Martin
Jody L
JL
Marber
Michael S
MS
Lever
Andrew M L
AM
D000328:Adult; D002460:Cell Line; D002478:Cells, Cultured; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D049452:Green Fluorescent Proteins; D015497:HIV-1 / Q000235:genetics*; D006352:Heart Ventricles; D006801:Humans; D007231:Infant, Newborn; D016086:Lentivirus / Q000235:genetics*; D008164:Luminescent Proteins / Q000032:analysis / Q000235:genetics; D008955:Models, Cardiovascular; D032342:Muscle Cells / Q000166:cytology*; D009206:Myocardium / Q000166:cytology*; D010957:Plasmids / Q000235:genetics; D011533:Proviruses / Q000235:genetics; D011994:Recombinant Proteins / Q000032:analysis; D014162:Transfection / Q000379:methods; D001616:beta-Galactosidase / Q000032:analysis / Q000235:genetics
D008164:Luminescent Proteins; D011994:Recombinant Proteins; D049452:Green Fluorescent Proteins; D001616:beta-Galactosidase